Martin Dubuc is the founder of SeqOne Genomics. Latest round: Growth. Backed by Elaia, IRDI Capital Investissement, Merieux Equity Partners.
Martin Dubuc is the Chief Executive Officer at SeqOne Genomics, a French HealthTech startup specializing in AI-powered clinical genomics. The company provides AI-powered software for next-generation sequencing (NGS) data analysis in oncology and rare diseases. Dubuc joined SeqOne's board of directors in October and was appointed CEO in January 2024. Prior to SeqOne Genomics, he headed Biogen’s Global Digital Health division and has over two decades of experience in the pharmaceutical industry at Pfizer, Merck&Co, and Biogen.
Full founder directory · Investor directory · Company funding database · Fundraising library